Bloy, Norma

Publications

Sort by

Co-Author Network

selected publications

Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine. 2023 Academic Article GET IT
Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence. Methods in cell biology. 2022 Academic Article GET IT
Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. Methods in cell biology. 2022 Academic Article GET IT
RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods in cell biology. 2022 Academic Article GET IT
Nicotinamide drives T cell activation in the mammary tumor microenvironment. Journal of translational medicine. 2022 Letter GET IT
Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods in cell biology. 2022 Academic Article GET IT
Times cited: 1
Metabolic features of cancer cells impact immunosurveillance. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 9
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR protocols. 2021 Academic Article GET IT
Times cited: 3
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER⁺ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 33
Autophagy-mediated metabolic effects of aspirin. Cell death discovery. 2020 Academic Article GET IT
Times cited: 217
MPA/DMBA-driven mammary carcinomas. Methods in cell biology. 2020 Academic Article GET IT
Times cited: 2
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
NK cells beat T cells at early breast cancer control. Oncoimmunology. 2020 Editorial Article GET IT
Times cited: 9
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology. 2020 Academic Article GET IT
Times cited: 156
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 58
Possible mechanisms of cancer prevention by nicotinamide. British journal of pharmacology. 2020 Review GET IT
Times cited: 8
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 83
Monitoring abscopal responses to radiation in mice. Methods in enzymology. 2019 Academic Article GET IT
Times cited: 2
Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 12
Immune effectors responsible for the elimination of hyperploid cancer cells. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 10
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological reviews. 2017 Review GET IT
Times cited: 61
Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells. Methods in molecular biology (Clifton, N.J.). 2017 Academic Article GET IT
Times cited: 8
The ratio of CD8⁺/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 11
Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 2016 Review GET IT
Times cited: 653
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer cell. 2016 Academic Article GET IT
Times cited: 347
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 2016 Review GET IT
Times cited: 40
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 46
Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 2015 Review GET IT
Times cited: 155
Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 2015 Review GET IT
Times cited: 18
Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 2015 Academic Article GET IT
Times cited: 11
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 2015 Review GET IT
Times cited: 122
Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 2015 Review GET IT
Times cited: 93
Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 2015 Academic Article GET IT
eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in cancer biology. 2015 Review GET IT
Times cited: 84
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Review GET IT
Times cited: 11
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Review GET IT
Times cited: 717
Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 2015 Review GET IT
Times cited: 5
Classification of current anticancer immunotherapies. Oncotarget. 2014 Review GET IT
Times cited: 340
Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 2014 Review GET IT
Times cited: 48
Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Review GET IT
Times cited: 264
Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 2014 Review GET IT
Times cited: 100
Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 658
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer. Oncogene. 2014 Academic Article GET IT
Times cited: 60
Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 2014 Review GET IT
Times cited: 23
Trial Watch: DNA vaccines for cancer therapy. Oncoimmunology. 2014 Review GET IT

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory awarded by United States Department of Defense Key Personnel 2021 - 2025

more ...

less ...

Background

education and training

M.Sc., University of Paris-Saclay (France) 2913
Ph.D., University of Paris-Saclay (France) 2017
B.S., University Paul Sabatier, Toulouse (France) 2011

Contact

full name

Norma Bloy

primary email

nob4001@med.cornell.edu

VIVO Weill Cornell Medical College

Norma Bloy Postdoctoral Associate in Radiation Oncology

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email